[EN] NOVEL AZABENZIMIDAZOLE TETRAHYDROPYRAN DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'AZABENZIMIDAZOLE TÉTRAHYDROPYRANE
申请人:MERCK SHARP & DOHME
公开号:WO2014031465A1
公开(公告)日:2014-02-27
Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPKactivated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.